AGGF1P8

Across TCGA pan-cancer cohorts, AGGF1P8 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated AGGF1P8 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher AGGF1P8 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated AGGF1P8 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

BLCA, THCA, and STAD are the cancer types where AGGF1P8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.470	0.625	.020	69	view →
THCA	DFS	Tertile	II,III,IV	0.131	0.764	.002	39	view →
STAD	OS	Tertile	II,III,IV	0.515	0.743	.017	39	view →
COAD	OS	Tertile	III,IV	0.140	0.783	.001	36	view →
UVM	OS	Tertile	All	0.218	0.696	.014	36	view →
LGG	DFS	Tertile	All	0.403	0.744	<.001	36	view →
ACC	OS	Tertile	II,III,IV	0.427	0.828	.001	33	view →
UCEC	OS	Tertile	IV	1.000	0.381	.026	24	view →
LUAD	OS	Tertile	All	0.468	0.705	.018	21	view →
KIRC	DFS	Tertile	All	0.617	0.870	.005	18	view →
LAML	DFS	Tertile	All	0.243	0.492	.041	12	view →
LIHC	OS	Tertile	II,III,IV	0.269	0.637	.033	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

AGGF1P8–BLCA (DFS)

Open the BLCA breakdown →